$257 million civil settlement with Wyeth over unlawful marketing of Rapamune

Main Category: Litigation / Medical Malpractice Also Included In: Pharma Industry / Biotech Industry Article Date: 01 Aug 2013 - 1:00 PDT Leading whistleblower law firm Grant & Eisenhofer P.A. represented two key whistleblowers behind a $257.4 million settlement announced between drugmaker Wyeth Pharmaceuticals, a subsidiary of Pfizer, and the U.S.

http://www.medicalnewstoday.com/releases/264177.php